Home
   
The Company
The History of SocraTec R&D
Our Goals and Visions
Our Services
Quality Management System
Cooperation Partners
Contact / Location
Clinical Investigations
Clinical Pharmacology Unit
Phase-I Studies
Phase-II/III Studies
Absorption-Site Studies
Proof-of-Concept Studies
Special Populations
Oncology
Magnetic Marker Monitoring
Procedure, Basic Principle
Testing Unit
Study Experience
Applications
Biopharmaceutics
Drug Substance
Dosage Form
BSC Classification
Product Improvement
Brain Trust, Expertise
Consulting Service
Expert Reports
Network of Experts
Development Concepts
Infocentre
Lectures/Presentations
Publications/Review Articles
Seminars/Conferences
Links
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Magnetic Marker Monitoring: new and fascinating perspectives

Gastrointestinal imaging has proved to be a valuable procedure for characterizing the performance of oral formulations during their transit along the GI-tract. It offers distinct advantages when compared to gamma-scintigraphy, e.g. the visualization of very rapid processes, the 3D-localization and the absence of exposure to radioactivity.

Information obtained with this procedure can be used in many ways e.g.:

To understand unexpected pharmacokinetic phenomena: The interpretation of unusual plasma concentration-time profiles of a drug, and these are not uncommon (e.g. double peaks) is difficult and usually speculative. In many of these cases application of the magnetic marker monitoring technique provides a better insight and makes it possible to find an explanation for the effects. The key to success often depends on knowing exactly how long a drug formulation remains in the stomach.

Localization of drug release in the gastrointestinal tract: Information on the location and kinetics of in-vivo drug release from a dosage form is decisive for the development of products with modified release and those for topical application to specific parts of the gastrointestinal tract. Investigations using magnetic marker monitoring provide the means for optimising such drug formulations.

In-vitro/in-vivo correlations: The standard procedure for establishing such a correlation often stretches the limits of interpretation, in most cases because of the lack of information on the performance of the product in the gastrointestinal-tract. This gap can be closed using the magnetic marker monitoring technique and thus, the reliability of conclusions reached may be greatly improved.


 
 
  © 2003-2013 SocraTec R&D GmbH deutsche Version Imprint